The George Institute for Global Health is a non-profit health and medical research institute whose mission is to improve the lives of millions of people worldwide through innovative health research. The George Institute prioritises clinical and population health research that produces outcomes that are easily translated into practice, and effect real change within a short period of time to health policy and practice.
The Institute has a global network of medical and health experts working together to address the leading causes of death and disability worldwide.
Established in 1999 in Australia and affiliated with The University of Sydney, the Institute today also has centres in China, India and the United Kingdom. It is affiliated with Peking University Health Science Center (PUHSC) in China, the University of Hyderabad in India and the University of Oxford in the United Kingdom.
The George Institute for Global Health at Peking University Health Science Center is one of the four global centres of The George Institute for Global Health, which is located in Beijing. Building and coordinating a broad alliance between governments, universities, hospitals, and other research organizations across China, the Institute has become a leading health organization in China after years of development with over 70 full-time staff. It attracts numerous international and domestic visiting fellows and interns every year to participate in its research projects.
The George Institute for Global Health at Peking University Health Science Center has four research programs - Hospital Care, Primary Care and Population Health, Diabetes Research, Biostatistics and Economic Evaluation - conducting research projects related to cardiovascular diseases, diabetes, nephropathy, injury, community health, school health and health policy.
With a special focus on the health issues affecting the population in China and the deficiencies of China’s health care system, the institute translates research outcomes into policy and practice, provides policy makers with effective, high-impact, and low-cost evidence, therefore to improve the performance of the system, and help address major health issues in China.